Journal Article
Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?
Brian K. Link
Current Hematologic Malignancy Reports, 2007, Volume 2, Number 4, Pages 219-224
Journal Article
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin’s lymphoma
Carl R. Willis, Amy Goodrich, Kathy Park, Jamie K. Waselenko and Margaret Lucas, et al.
Annals of Hematology, 2006, Volume 85, Number 5, Pages 301-307
Journal Article
Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy
M. Dreyling, L. Trümper, C. von Schilling, M. Rummel and U. Holtkamp, et al.
Annals of Hematology, 2007, Volume 86, Number 2, Pages 81-87
Journal Article
The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer
Takashi Hirose, Yoshihide Mizutani, Tohru Ohmori, Hiroo Ishida and Takamichi Hosaka, et al.
Cancer Chemotherapy and Pharmacology, 2006, Volume 58, Number 3, Pages 361-367
Journal Article
Integration of novel agents in the treatment of colorectal cancer
Syma Iqbal and Heinz-Josef Lenz
Cancer Chemotherapy and Pharmacology, 2004, Volume 54, Supplement 1, Pages S32-S39
Journal Article
Treatment of metastatic breast cancer: looking towards the future
Surabhi Amar, Vivek Roy and Edith A. Perez
Breast Cancer Research and Treatment, 2009, Volume 114, Number 3, Pages 413-422
Journal Article
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
Takashi Hirose, Takao Shirai, Hiroo Ishida, Kohichi Ando and Tomohide Sugiyama, et al.
Cancer Chemotherapy and Pharmacology, 2007, Volume 60, Number 2, Pages 267-274
Journal Article
Open AccessTreatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial
Mathias Witzens-Harig, Manfred Hensel, Michael Unterhalt and Klaus Herfarth
BMC Cancer, 2011, Volume 11, Number 1, 87
Journal Article
Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma
Michal Sieniawski, Oliver Staak, Jan-Peter Glossmann, Thorsten Reineke and Helena Scheuß, et al.
Annals of Hematology, 2007, Volume 86, Number 2, Pages 107-115
Journal Article
Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response
Siddhartha Ganguly, Clint L. Divine, Delva Deauna-Limayo, David C. Bodensteiner and James D. Cook, et al.
Annals of Hematology, 2005, Volume 84, Number 8, Pages 526-531